Last Week’s GER IPO Research: Tencent Music, IPO Trading Strategy Deep Dive, WuXi, Junshi & Xinyi
Another busy week for IPO research from the GER team. This week, we recap the Tencent Music Entertainment (TME US) IPO which we noted is more...
425 Views
Junshi Bioscience (君实医药) IPO: Rich Valuation, but Catalyst Ahead
Shanghai Junshi Biosciences, a China-based biotechnology company listed on the NEEQ market (ticker 833330.NEEQ) with a market capitalization of USD...
802 Views
Junshi Biosciences IPO Valuation: Sensibly Priced with Upside at the Low-End
Shanghai Junshi Bioscience Co. Ltd. (1387344D CH) launched its Hong Kong IPO today. The mid-point of Junshi's IPO price range of HK$19.38-20.38 per...
501 Views
Last Week's GER IPO Research: Tencent Music, Softbank, Weimob, Luzhou, Junshi, Yancoal and Asiainfo
We had another busy week for IPO research the GER team. This week, we recommend participating in the Tencent Music Entertainment (TME US) IPO,...
491 Views
Junshi Bioscience (君实医药) IPO: Thoughts on Valuation (Part 2)
Shanghai Junshi Biosciences, a China-based biotechnology company listed on the NEEQ market (ticker 833330.NEEQ) with a market capitalization of USD...
643 Views